Jupiter Neurosciences, Inc.
- JUNS
- NASDAQ
- Biotechnology
- Neuro-inflammation Drugs
- Resveratrol Therapeutics
$2.75
Today −5.34%Quote Oct 19, 2026, 08:00 PM UTC
−3.85%over the last month
Max drawdown −18.8%From 1-month high −18.2%3 months −78.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Jupiter Neurosciences
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
5
Founded
2016
Market value
$2.1M
Quote Oct 19
Floor
$2.35
14.5% below price
Resistance
$2.76
0.4% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about JUNSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free